January 16, 2018
Rose
Owkin, a predictive analytics company that aims to accelerates drug discovery and development, just landed $11 million in Series A funding. The round was led by Otium Venture with participation from Cathay Innovation, Plug and Play, and NJF Capital. This announcement brings the company’s total funding to $13.1 million.
from MobiHealthNews http://ift.tt/2DgXQIJ
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment